Literature DB >> 19017565

Refractory and lethal status epilepticus in a patient with ring chromosome 20 syndrome.

Julia Jacobs1, Geneviève Bernard, Eva Andermann, François Dubeau, Frederick Andermann.   

Abstract

PURPOSE: The only consistent symptom of ring chromosome 20 syndrome (r(20)) is severe, refractory epilepsy often associated with a characteristic, although not pathognomonic, EEG pattern. Patients suffer from severe seizures with accompanying cognitive decline and frequent episodes of non-convulsive status epilepticus (SE). Other features of this rare disorder, such as dysmorphic changes, mental retardation and behavioral disturbances are variable. Because of the variability of the clinical presentation, some patients with r(20) undergo invasive investigations before being diagnosed. CASE STUDY: We present the case of a young boy with no dysmorphic traits, who was only diagnosed with r (20) syndrome at the age of 13. His first seizure occurred at the age of four. Later seizures were of various types including non-convulsive SE, with deterioration of the background EEG and severe cognitive decline. Despite multiple trials of anti-epileptic medications, his seizures remained highly refractory, and he died as the result of an uncontrollable, prolonged SE, shortly after the diagnosis was made. DISCUSSION: Non-convulsive SE is common in patients with r(20) syndrome and may be caused by a dysfunction in dopaminergic neurotransmission. However, until now, no case of lethal status epilepticus has been reported. This case report suggests that patients with unexplained refractory seizures and episodes of non-convulsive SE should undergo genetic testing early in their disease, even in the absence of any morphologic features or dysmorphic traits suggestive of a chromosomal disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19017565     DOI: 10.1684/epd.2008.0212

Source DB:  PubMed          Journal:  Epileptic Disord        ISSN: 1294-9361            Impact factor:   1.819


  2 in total

1.  Successful Treatment of Drug-Resistant Seizures Secondary to Ring 20 Mosaicism with Perampanel as an Add-On Antiepileptic Drug.

Authors:  Janet Ling; Wai Lan Yeung; Kam Lun Hon; Ivan F M Lo; Ho-Ming Luk; Cheuk Wing Fung; Alexander K C Leung
Journal:  Case Rep Pediatr       Date:  2022-05-26

2.  Epilepsy in Ring Chromosome 20 Syndrome Might Have Variable Clinical Features.

Authors:  Abhijit Anil Patil; K P Vinayan; Arun Grace Roy
Journal:  Ann Indian Acad Neurol       Date:  2020-06-05       Impact factor: 1.383

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.